Engineering cartilage to improve healing in osteoarthritis
Molecular Engineering of Cartilage PCM Mechanotransduction in Osteoarthritis Using Biomimetic Proteoglycans
['FUNDING_R01'] · VILLANOVA UNIVERSITY · NIH-10869996
This study is working on creating new materials that mimic natural cartilage to help improve healing in people with osteoarthritis, aiming to make treatments better so you can feel less pain and move more easily.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | VILLANOVA UNIVERSITY (nih funded) |
| Locations | 1 site (VILLANOVA, UNITED STATES) |
| Trial ID | NIH-10869996 on ClinicalTrials.gov |
What this research studies
This research focuses on developing new biomimetic proteoglycans to enhance the healing of cartilage affected by osteoarthritis. By engineering the pericellular matrix surrounding cartilage cells, the study aims to improve how these cells respond to mechanical signals, which is crucial for cartilage regeneration. The approach involves creating a synthetic version of the natural cartilage matrix to support cell function and promote healing. Patients may benefit from advancements in treatments that could alleviate pain and restore function in osteoarthritis.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with osteoarthritis, particularly those experiencing significant cartilage degeneration.
Not a fit: Patients with osteoarthritis who have already undergone extensive joint surgeries or have advanced joint damage may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments that significantly improve cartilage healing and reduce pain for osteoarthritis patients.
How similar studies have performed: While the approach of engineering the pericellular matrix is innovative, similar strategies in cartilage regeneration have shown promise in preliminary studies.
Where this research is happening
VILLANOVA, UNITED STATES
- VILLANOVA UNIVERSITY — VILLANOVA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MARCOLONGO, MICHELE S — VILLANOVA UNIVERSITY
- Study coordinator: MARCOLONGO, MICHELE S
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.